The deal is set to help Vertex’s development of next-generation gene editing therapies for sickle cell disease and ...

New research by Security Intelligence has revealed security risks in MLOps platforms including Azure ML, BigML and Google ...

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 7: NextNav ...

Vertex aims to further bolster its gene-editing therapy pipeline by using Orna's lipid nanoparticle delivery technologies during the three-year collaboration.